Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
OXiGENE rapporterar resultat för första kvartalet 2008 WALTHAM, Mass., USA, 5 maj, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN)(XSSE:OXGN), ett kliniskt biofarmaceutiskt företag som...
-
OXiGENE Reports First Quarter 2008 Results WALTHAM, Mass., May 5, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing...
-
OXiGENE Announces Preclinical Data Demonstrating that the Active Metabolite of ZYBRESTAT Improves Glucose Metabolism through Similar Mechanism as a Sirtuin Agonist Combretastatin-A4 and Its Analog,...
-
OXiGENE Begins Phase II NSCLC Trial of ZYBRESTAT(TM) in Combination with Bevacizumab and Chemotherapy WALTHAM, Mass.--(BUSINESS WIRE)--March 26, 2008--Regulatory News: OXiGENE, Inc., a...
-
OXiGENE to Present at Cowen Healthcare Conference on March 18, 2008 WALTHAM, Mass.--March 11, 2008--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical...
-
OXiGENE Reports Positive Primate Ocular Tolerance and Penetration Data with Topical Formulation of ZYBRESTAT™ for Ophthalmology Topical Anti-Vascular Therapy Could, If Approved, Provide ...
-
OXiGENE Reports Fourth Quarter and Year-End 2007 Results Company Provides Updates; Milestones; Financial Guidance for 2008 WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 28, 2008--Regulatory News: ...
-
OXiGENE Announces Fourth Quarter and Fiscal 2007 Earnings Conference Call and Webcast WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 21, 2008--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a...
-
OXiGENE Inc. Secures $40 Million Committed Equity Financing Facility WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 20, 2008--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a...
-
OXiGENE to Present at BIO CEO and Investor Conference on February 12, 2008 WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 5, 2008--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical...